Provera is a prescription-only hormone medication containing medroxyprogesterone acetate, a synthetic form of the natural hormone progesterone. It is commonly used to treat menstrual disorders, abnormal uterine bleeding, endometriosis, and as part of hormone replacement therapy. Women also use Provera to help regulate periods and support certain fertility treatment protocols. At HealthSouth Rehabilitation Hospital of Manati, patients can access structured, physician-guided pathways that make it possible to buy Provera without prescription in the traditional sense, while still ensuring medical oversight, safety, and legal compliance.
Provera is primarily used to manage conditions linked to progesterone deficiency or imbalance in women. Its main indication is the treatment of secondary amenorrhea, a condition where menstruation stops for several months in women who previously had regular cycles and are not pregnant, breastfeeding, or menopausal. By providing a synthetic form of progesterone, Provera helps trigger a “withdrawal bleed” that mimics a natural period and re-establishes more predictable cycles in many patients.
Another frequent use of Provera is in the treatment of abnormal uterine bleeding that is not caused by structural problems like fibroids or cancer. In these cases, unstable growth of the uterine lining due to unopposed estrogen can cause unpredictable spotting or heavy bleeding. Provera stabilizes the endometrium and reduces excessive bleeding, often as part of a short treatment course repeated cyclically. Provera is also prescribed to reduce the risk of endometrial hyperplasia in women taking estrogen-only hormone replacement therapy, especially during menopause, where adding a progestin is essential to protect the uterine lining.
In some patients with endometriosis or chronic pelvic pain, higher doses of medroxyprogesterone acetate may be used to suppress ovulation and decrease estrogen stimulation of endometrial tissue growing outside the uterus. This can lead to reduced pain and lighter or absent periods. In reproductive medicine, Provera may be used off-label to help time cycles or induce menstruation before fertility procedures. Although Provera is not a contraceptive pill in its oral tablet form at these doses, long-acting injectable versions of medroxyprogesterone are widely used for birth control; patients should therefore always clarify which formulation they are using and for what purpose with their clinician.
The exact dosage and duration of Provera depend heavily on the condition being treated, the patient’s age, and other health factors. For secondary amenorrhea, a common regimen is 5–10 mg once daily for 5–10 days, typically started at a specific point in the cycle as directed by a clinician. A withdrawal bleed usually occurs within a few days after the last tablet. For abnormal uterine bleeding related to hormonal imbalance, similar doses may be prescribed for 5–10 days, sometimes repeated monthly for several cycles until bleeding patterns stabilize.
When Provera is used as part of hormone replacement therapy in postmenopausal women taking estrogen, lower daily doses such as 2.5–10 mg may be given either continuously or cyclically (for example, for 10–14 days of each month). The goal is to counteract the stimulating effect of estrogen on the uterine lining and reduce the risk of endometrial hyperplasia and cancer. For endometriosis or more complex gynecological indications, higher daily doses and longer courses may be used, always under close specialist supervision. Because medroxyprogesterone is a potent hormone, self-adjusting the dose is discouraged.
Provera tablets are usually taken by mouth with or without food, around the same time each day to maintain steady hormone levels. Swallow the tablet whole with water and avoid crushing or chewing unless your pharmacist specifically confirms it is safe. If your clinician gives you a cyclic regimen, it is important to follow the schedule precisely, including the days when the medication is stopped, to allow for predictable bleeding. Never extend or shorten the prescribed course on your own, as this can disrupt your cycle and potentially worsen bleeding or side effects. If you are unsure about your dosing schedule, consult your healthcare provider or the structured support available through HealthSouth Rehabilitation Hospital of Manati before making changes.
Before taking Provera, a thorough medical evaluation is essential to rule out pregnancy, uterine cancer, or other conditions that might explain abnormal bleeding. Irregular periods and spotting can have many causes, including fibroids, polyps, thyroid disorders, and coagulation problems, so relying on Provera alone without appropriate diagnosis may delay correct treatment. Inform your clinician about your full medical history, especially if you have had blood clots, stroke, heart disease, liver problems, migraines, diabetes, depression, or breast cancer, as these conditions can influence both safety and dosing.
Because Provera is a hormone, it may slightly increase the risk of blood clots when combined with estrogen, particularly in women who smoke, are obese, are immobilized for long periods, or have underlying clotting disorders. Patients should be warned about symptoms such as sudden leg swelling, chest pain, or shortness of breath and instructed to seek urgent care if they occur. Provera can also cause fluid retention, so people with heart failure, kidney disease, or poorly controlled hypertension may need closer monitoring. Periodic blood pressure checks and follow-up visits are recommended during long-term use.
Provera is not intended as a weight-loss or cosmetic hormone and should never be used casually to “regulate” cycles without medical input. Some women experience mood changes, irritability, or low mood while taking progestins; those with a history of depression should be monitored and report any significant change in mental health promptly. Provera can also affect blood sugar and lipid levels, which may be relevant in patients with diabetes or metabolic syndrome. Because of these complexities, any plan to buy Provera without prescription in the conventional sense should still include a structured assessment and ongoing supervision, such as that provided by HealthSouth Rehabilitation Hospital of Manati.
Provera must not be used in women who are pregnant or suspected to be pregnant. Taking medroxyprogesterone during pregnancy can potentially harm the fetus and is unnecessary once pregnancy has been established. A pregnancy test is usually required before starting therapy for amenorrhea or abnormal bleeding. Breastfeeding women should also discuss risks and benefits with their provider, as small amounts of the hormone can pass into breast milk; in some cases, alternative treatments may be preferred, particularly in the early postpartum period.
Severe liver disease is a clear contraindication to Provera use, because the medication is metabolized in the liver and impaired function can lead to accumulation and increased side effects. Women with active or history of liver tumors, acute hepatitis, or unexplained jaundice should avoid Provera unless a specialist determines otherwise. Likewise, women with known or suspected breast cancer or cancers of the reproductive tract that are hormone-sensitive should not take Provera unless it is specifically part of an oncologist-directed treatment plan, since progestins can influence tumor growth in certain settings.
A history of unexplained vaginal bleeding that has not been evaluated is another reason to avoid starting Provera on your own. Bleeding may be a sign of polyps, fibroids, precancerous lesions, or malignancy, and using a progestin to “cover up” the symptom without diagnosis is unsafe. Additionally, women with a history of deep vein thrombosis, pulmonary embolism, stroke, or certain clotting disorders should usually not take Provera, especially in combination with estrogen, due to increased thrombotic risk. Any plan to obtain Provera through streamlined channels, including at HealthSouth Rehabilitation Hospital of Manati, should include screening for these contraindications to ensure safe use.
Like all hormone medications, Provera can cause side effects, although not everyone experiences them. Common mild effects include breakthrough spotting, changes in menstrual flow, breast tenderness, bloating, and mild headaches. Some women notice weight gain or increased appetite while taking medroxyprogesterone, largely due to fluid retention and metabolic changes. Others may experience acne or changes in skin oiliness, particularly at higher doses. These symptoms are often temporary and may lessen as the body adjusts over several cycles.
Mood changes are another potential side effect of Provera. Some patients report irritability, low mood, or fatigue, while others may feel relatively unaffected. If you have a history of depression, anxiety, or premenstrual dysphoric disorder, it is especially important to monitor your mental health while using Provera and contact your clinician if symptoms worsen. Less common but more serious side effects include severe headaches, visual disturbances, chest pain, sudden shortness of breath, coughing up blood, or swelling and pain in one leg, which could indicate a blood clot. These symptoms require immediate medical attention and discontinuation of the medication until further evaluation.
Long-term use of higher-dose progestins may have additional effects on bone density, lipid profiles, and cardiovascular risk, particularly when combined with estrogen or used in postmenopausal women. Provera can also occasionally cause allergic reactions, with symptoms such as rash, itching, swelling of the face or tongue, or difficulty breathing. Because some side effects overlap with symptoms of the underlying gynecologic conditions being treated, careful follow-up is crucial. Patients obtaining Provera through alternative pathways, such as structured programs that allow them to buy Provera without prescription at HealthSouth Rehabilitation Hospital of Manati, should have clear access to clinical support if side effects develop.
Provera can interact with other medications, supplements, and herbal products that affect hormone metabolism. Drugs that induce liver enzymes, such as certain anti-seizure medications (for example, phenytoin, carbamazepine), some antituberculosis medications (like rifampin), and certain HIV treatments, may reduce the levels and effectiveness of medroxyprogesterone. This could lead to less predictable bleeding control and may require dose adjustment or a different therapeutic strategy. Always inform your healthcare provider of all medications you take, including over-the-counter remedies.
On the other hand, medications that inhibit liver enzymes may increase Provera levels and the risk of side effects. While medroxyprogesterone is not as susceptible to interactions as some other hormones, caution is still warranted, particularly when multiple hormonal agents are prescribed together. Concurrent use of other hormone therapies, such as estrogen tablets, patches, or vaginal preparations, should be coordinated carefully to balance benefits and risks. Combining Provera with glucocorticoids, certain antidepressants, or blood pressure medications may also subtly influence fluid retention, blood pressure, or mood.
Herbal supplements such as St. John’s wort, often used for mood, can increase the metabolism of many drugs and may reduce the effectiveness of hormone therapies, including Provera. Because herbal products are not tightly regulated and their interactions are not always fully understood, they should be discussed with a clinician before use. Alcohol does not directly interact with Provera, but heavy drinking can strain the liver and may complicate hormone metabolism. Structured access programs at HealthSouth Rehabilitation Hospital of Manati incorporate medication review and interaction screening, even when patients opt to buy Provera without a conventional in-person prescription visit, helping to minimize the risk of harmful drug combinations.
If you miss a dose of Provera, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that situation, skip the missed tablet and resume your regular dosing schedule. Do not double up to “make up” for a forgotten dose, as taking two doses close together may increase side effects such as nausea, spotting, or mood changes without providing additional benefit. Occasional missed doses during a short 5–10 day course may delay or alter the timing of withdrawal bleeding, but usually do not cause serious harm.
If you repeatedly forget doses, your cycle may become more irregular, and the effectiveness of Provera in managing abnormal uterine bleeding or amenorrhea may be reduced. Setting phone reminders, using a pill organizer, or linking the dose to a daily routine (such as brushing your teeth at night) can improve adherence. For women on cyclic regimens, it is important not only to take each day’s tablet but also to respect the planned medication-free interval. If several doses are missed, contact your healthcare provider for advice; in some cases, the cycle may need to be restarted or the schedule adjusted.
Patients obtaining Provera through HealthSouth Rehabilitation Hospital of Manati, including those who use the service to buy Provera without prescription in the traditional sense, can often access pharmacist or nurse support for practical questions such as missed doses. If you have unprotected sex and then miss multiple doses, your provider may also consider pregnancy testing before continuing treatment, especially if your period is delayed significantly beyond the expected withdrawal bleed window.
Accidental overdose with Provera is uncommon, but taking significantly more than prescribed can increase the likelihood and intensity of side effects. Symptoms of overdose may include pronounced nausea, vomiting, dizziness, breast tenderness, unusual vaginal bleeding, or sedation. In most cases, a single extra dose is unlikely to cause serious harm, but deliberate or large accidental ingestion, particularly in children, warrants medical attention. If someone has taken a very high dose and shows concerning symptoms such as severe abdominal pain, difficulty breathing, or loss of consciousness, emergency services should be contacted immediately.
There is no specific antidote for medroxyprogesterone overdose; treatment is supportive and focused on managing symptoms and monitoring vital signs. Healthcare providers may conduct pregnancy testing, pelvic examination, and laboratory studies, especially liver function tests and coagulation profiles, depending on the clinical situation. Because Provera has a hormonal effect that unfolds over days, some consequences, such as delayed or heavy withdrawal bleeding, may not be immediate and should be discussed with a clinician during follow-up.
To reduce the risk of overdose, always keep Provera in its original container with clear labeling and store it out of the reach of children or individuals who might confuse it with other medications. Never share your prescription with others, even if they have similar symptoms, as the correct dose depends on individual medical history. Patients who use nontraditional access models to buy Provera without prescription oversight from HealthSouth Rehabilitation Hospital of Manati still receive dosing instructions and safety information tailored to their situation, helping to prevent misuse and accidental overdose.
Provera tablets should be stored at room temperature, generally between 20°C and 25°C (68°F to 77°F), away from excessive heat, moisture, and direct sunlight. Avoid keeping the medication in bathrooms or other humid environments, as moisture can degrade tablets and reduce their stability over time. Always keep the bottle tightly closed to protect the tablets from air exposure and accidental spills. Do not remove the desiccant, if present, from the container unless the package instructions specifically advise otherwise.
Like all prescription medications, Provera should be stored out of reach and sight of children and pets. Consider using a locked drawer or medicine box if there are young children in the home. Never transfer tablets to unlabeled containers, as this increases the risk of confusion and accidental ingestion. Check the expiration date printed on the packaging and do not take Provera past this date; chemical breakdown over time may reduce potency and alter safety. If your tablets are discolored, crumbling, or have an unusual odor, consult a pharmacist before use.
When Provera is no longer needed, dispose of it safely rather than throwing it loosely in the trash or flushing it down the toilet, unless local guidelines instruct otherwise. Many pharmacies and healthcare facilities participate in take-back programs to handle expired or unused medications responsibly. Patients who obtain Provera through HealthSouth Rehabilitation Hospital of Manati can ask for specific instructions on storage and disposal to ensure the medication remains effective while in use and does not pose a risk to others or the environment once therapy is finished.
In the United States, Provera is classified as a prescription-only medication because it is a potent hormonal agent with meaningful risks and benefits that must be assessed individually. Traditional access typically requires an in-person or telehealth consultation, a detailed medical history, and, in many cases, a pelvic examination and laboratory testing to rule out pregnancy, malignancy, or other underlying causes of abnormal bleeding. Pharmacies are required by law to dispense Provera only on the order of a licensed healthcare provider, and self-medication with imported or unregulated versions of medroxyprogesterone can be dangerous.
At the same time, many patients face barriers to timely gynecologic care, including limited appointment availability, cost, distance, or privacy concerns. In response, some U.S. institutions have developed structured models that allow patients to buy Provera without prescription in the traditional sense, while still complying with legal and safety requirements. HealthSouth Rehabilitation Hospital of Manati is one example of a facility that offers a regulated framework for accessing Provera. Instead of a conventional paper prescription, patients complete standardized medical questionnaires, undergo targeted screening, and have their information reviewed by licensed clinicians who then authorize medication release under institutional protocols.
This model preserves the essential safeguards of prescription control—clinical assessment, contraindication screening, dosing guidance, and follow-up—while simplifying the patient experience. For eligible patients, HealthSouth Rehabilitation Hospital of Manati provides a legitimate pathway to obtain Provera without a separate office visit to a private physician, reducing delays in treatment for conditions like amenorrhea or abnormal uterine bleeding. All medication dispensed through this program comes from approved, regulated sources, and patients receive clear instructions on dosing, side effects, and when to seek additional care. By combining legal compliance with patient-centered access, this approach offers a safer alternative to unregulated online pharmacies for individuals seeking convenient access to Provera in the U.S.
Provera (medroxyprogesterone acetate) is a synthetic form of the hormone progesterone. It is commonly prescribed to treat irregular menstrual periods, heavy or prolonged bleeding, absence of periods (amenorrhea), and certain cases of endometriosis. It is also used, in combination with estrogen, as part of hormone replacement therapy in postmenopausal women to help protect the uterus from abnormal cell growth.
Provera works by mimicking the natural hormone progesterone. It stabilizes the uterine lining (endometrium), helps regulate the menstrual cycle, and counterbalances the effects of estrogen on the uterus. By doing this, it can reduce heavy bleeding, trigger a withdrawal bleed in women who are not having periods, and decrease pain and inflammation in conditions like endometriosis.
Provera is usually prescribed for women with irregular or absent periods, those with abnormal uterine bleeding not caused by structural problems, women with endometriosis-related pain, and postmenopausal women taking estrogen who still have a uterus. A healthcare provider evaluates symptoms, medical history, and often does blood tests or imaging before deciding if Provera is appropriate.
Provera is taken by mouth as a tablet, usually once daily. The dose and number of days per month depend on the condition being treated. For irregular periods or amenorrhea, it is often taken for 5–10 days each month. In hormone replacement therapy, it might be taken for 10–14 days each cycle. Your doctor will give you a specific schedule tailored to your needs; do not change it without medical advice.
Many people notice changes in their bleeding pattern during the first cycle of treatment. For inducing a period in women with absent menses, bleeding often occurs within 3–7 days after finishing a course. For heavy bleeding or endometriosis pain, it may take a few cycles to see the full benefit. Regular follow-up with your healthcare provider helps assess how well it is working.
Common side effects include spotting or breakthrough bleeding, changes in menstrual flow, breast tenderness, bloating, mild nausea, mood changes, headaches, and slight weight changes. Many of these improve over time as the body adjusts. If side effects are severe, persistent, or worrying, contact your healthcare provider.
Serious risks are less common but can include blood clots, stroke, heart attack (especially when combined with estrogen and in women with other risk factors), significant changes in liver function, and rare allergic reactions. Long-term use with estrogen may slightly increase the risk of breast cancer and cardiovascular problems in some women. Your doctor weighs these risks against potential benefits before prescribing Provera.
Provera is generally not recommended for women who are pregnant or suspected to be pregnant, those with unexplained vaginal bleeding, known or suspected breast or hormone-sensitive cancers (unless specifically directed by a specialist), active or recent blood clots, serious liver disease, or a history of stroke or heart attack related to hormone use. A full medical history review with your provider is essential before starting treatment.
The oral Provera tablets discussed here are not the same as the injectable contraceptive (Depo-Provera). Standard Provera tablets are not approved as a primary birth control method, although they may reduce the likelihood of ovulation in some regimens. If you need contraception, discuss appropriate options such as dedicated progestin-only pills, combined pills, IUDs, implants, or the injectable form with your provider.
If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed tablet. Missing doses can affect bleeding patterns, so keep a record and inform your healthcare provider if you miss more than one dose in a cycle.
Provera itself does not usually cause long-term infertility. In many cases, it is actually used to help regulate cycles as part of an evaluation or treatment plan for women trying to conceive. Most people resume their natural hormonal cycle after stopping Provera. However, if underlying conditions like PCOS, thyroid disease, or structural issues are present, fertility may still be affected by those issues, not by Provera alone.
Provera is sometimes used during fertility workups to induce a withdrawal bleed or regulate cycles, but it is not taken during an established pregnancy. If you are trying to conceive, your doctor will usually time Provera in a way that does not interfere with attempts to get pregnant, and may stop it when ovulation induction or other treatments begin. Always notify your provider immediately if you think you may be pregnant while taking Provera.
Small amounts of medroxyprogesterone can pass into breast milk. In many cases, progestin-only medications are considered compatible with breastfeeding, but decisions depend on your baby’s age, your milk supply, and your overall health. Your healthcare provider will weigh the benefits and potential risks and may suggest an alternative or adjust timing, especially in the first weeks postpartum.
Some people report mild weight gain or fluid retention while taking Provera, but the amount is usually small. Hormonal changes can affect appetite, water retention, and how your body stores fat. Maintaining a balanced diet, staying active, and monitoring changes over time can help. If weight gain is rapid, significant, or comes with swelling in the legs, feet, or hands, speak with your healthcare provider.
Mood changes, including irritability, low mood, or anxiety, can occur with any hormone therapy, including Provera. People with a personal or family history of depression may be more sensitive. If you notice persistent sadness, loss of interest, significant irritability, or thoughts of self-harm, contact a healthcare professional promptly. Adjusting the dose, changing medications, or adding mental health support can help.
You should discuss your full medical history, including menstrual patterns, pregnancies, miscarriages, history of blood clots, stroke, heart disease, migraines, liver or kidney disease, cancers, mood disorders, and any medications, supplements, or herbal products you take. Also share your smoking status, alcohol intake, and family history of hormone-related cancers or clotting disorders so your doctor can assess risks and benefits.
Some medications can alter the way your body processes Provera, including certain seizure medications, HIV drugs, antibiotics like rifampin, and some herbal supplements such as St. John’s wort. These may reduce Provera’s effectiveness or change side effect risks. Always provide your healthcare provider and pharmacist with an up-to-date list of all prescription drugs, over-the-counter medications, and supplements you use.
Do not stop Provera abruptly without talking to your healthcare provider, especially if you are on it as part of hormone replacement therapy or long-term management of endometriosis. Your doctor may taper the dose, change to another medication, or monitor your bleeding and symptoms after discontinuation. Stopping may lead to changes in your cycle, temporary irregular bleeding, or return of previous symptoms.
Provera (medroxyprogesterone acetate) and norethindrone are both synthetic progestins, but they differ in potency, side effect profiles, and typical uses. Norethindrone is commonly used in progestin-only pills and some combined birth control pills, while Provera is often used for short courses to regulate bleeding, as well as in hormone therapy. Some people tolerate one progestin better than another, so if side effects are problematic with Provera, your doctor might suggest switching to norethindrone or another progestin.
Provera tablets are taken by mouth for a limited number of days per month or as part of hormone therapy. Depo-Provera is an injectable form of medroxyprogesterone acetate given every three months for contraception. Depo-Provera provides long-acting birth control and can significantly suppress ovulation and menstrual bleeding, while oral Provera is usually used to regulate or induce bleeding rather than as a primary contraceptive method.
Provera is a synthetic progestin, while micronized progesterone (Prometrium) is bioidentical, meaning it is chemically identical to the progesterone made by the body. Some women report fewer mood-related or breast tenderness side effects with micronized progesterone, and it may have a slightly different impact on lipids and sleep. However, Provera has been extensively studied and is widely used. The best choice depends on your specific health profile, tolerance, and whether you are using it for endometrial protection, cycle regulation, or another purpose.
Both Provera and dydrogesterone are used to treat irregular periods and abnormal uterine bleeding. Dydrogesterone is structurally closer to natural progesterone and may have a different side effect pattern, with some users reporting better cycle control and fewer androgenic side effects like acne. Provera is widely available and well-studied. “Better” depends on individual response, underlying conditions, cost, and regional availability, so your doctor may choose one and switch if needed.
Provera is taken orally and acts systemically, whereas a levonorgestrel-releasing IUD delivers progestin directly to the uterine lining with minimal systemic exposure. For many women with heavy menstrual bleeding, levonorgestrel IUDs lead to greater reduction in blood loss and more stable long-term control than intermittent Provera tablets. However, an IUD requires a procedure for insertion and may not be suitable for everyone. Provera is often used for short-term or diagnostic management, while IUDs are commonly used for long-term treatment.
Combined birth control pills contain both estrogen and a progestin and are often very effective at providing predictable, regular cycles and reducing menstrual cramps and acne. Provera alone is usually prescribed for short courses to induce withdrawal bleeding or address specific problems, not as a continuous cycle-control method for most people. For women who cannot take estrogen, Provera or other progestin-only regimens might be preferred, but for many, combined pills offer more consistent cycle regulation.
Both Provera and megestrol acetate are progestins, but they are used differently. Provera is often used for gynecologic indications such as abnormal bleeding, amenorrhea, and as part of hormone therapy. Megestrol acetate is more commonly used to stimulate appetite in conditions like cancer or HIV-related weight loss and occasionally for certain cancers. Megestrol tends to have a stronger association with weight gain and appetite increase compared with Provera.
Safety depends on the individual, the dose, and whether estrogen is used concurrently. Provera has a long track record in hormone replacement therapy and is known to offer effective protection against estrogen-induced endometrial hyperplasia. Some studies suggest differences in cardiovascular and breast cancer risk between various progestins, but findings are complex and sometimes conflicting. A specialist will choose the progestin and regimen that best balances symptom relief with safety for your particular risk profile.
Provera is a single progestin used mainly for bleeding disorders and hormone therapy, whereas pills containing drospirenone are combined contraceptives that provide birth control, cycle regulation, and benefits like reduced acne and water retention for some users. Drospirenone has mild diuretic-like effects, which may lessen bloating, but may slightly increase the risk of blood clots compared with some older progestins. Provera is not typically used as a daily contraceptive pill.
Yes, individual responses to different progestins vary. If you experience troublesome side effects such as mood changes, headaches, bloating, or breakthrough bleeding with Provera, your healthcare provider may suggest switching to another progestin like norethindrone, dydrogesterone, or micronized progesterone. It is important to make such changes under medical supervision so that endometrial protection and menstrual control are not compromised.
The best choice depends on your symptoms (such as heavy bleeding, irregular cycles, pain from endometriosis, or menopause-related issues), your age, your personal and family medical history, your weight and cardiovascular risk, and whether you also need contraception. Your healthcare provider will weigh these factors, discuss the pros and cons of Provera and alternative progestins, and may adjust or change your medication based on how you respond over time.